Showing results (61-70 of 606) with videos related to
Sort By:
Pageof 61
The Journal of Steroid Biochemistry and Molecular Biology|October 29, 2011
Control of metabolism by nutrient-regulated nuclear receptors acting in the brainKadiombo Bantubungi, Janne Prawitt, Bart StaelsBiochimica Et Biophysica Acta|November 8, 2011
Roles of PPARs in NAFLD: potential therapeutic targetsAnne Tailleux, Kristiaan Wouters, Bart StaelsTrends in Endocrinology and Metabolism: TEM|April 20, 2012
Thiazolidinediones and PPARγ agonists: time for a reassessmentBertrand Cariou, Bernard Charbonnel, Bart StaelsCurrent Opinion in Pharmacology|September 16, 2006
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndromeCatherine Fiévet, Jean-Charles Fruchart, Bart StaelsNature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptorsPhilippe Gervois, Jean-Charles Fruchart, Bart StaelsDiabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart StaelsCurrent Opinion in Lipidology|September 23, 2003
Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and functionGiulia Chinetti, Jean-Charles Fruchart, Bart StaelsImmunological Reviews|October 17, 2014
Macrophage phenotypes in atherosclerosisSophie Colin, Giulia Chinetti-Gbaguidi, Bart StaelsMolecular Metabolism|October 3, 2020
Dysregulated lipid metabolism links NAFLD to cardiovascular diseaseAudrey Deprince, Joel T Haas, Bart StaelsAnnual Review of Physiology|December 16, 2015
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver DiseaseJoel T Haas, Sven Francque, Bart StaelsPageof 61